Clinical implications of metastatic lymph node ratio in gastric cancer
2007

Metastatic Lymph Node Ratio in Gastric Cancer

Sample size: 224 publication Evidence: high

Author Information

Author(s): Liu Caigang, Lu Ping, Lu Yang, Xu Huimian, Wang Shubao, Chen Junqing

Primary Institution: First Affiliated Hospital of China Medical University

Hypothesis

Is the metastatic lymph node ratio a reliable classification of lymph node metastasis in gastric cancer in Chinese patients?

Conclusion

The metastatic lymph node ratio is a simple and useful independent prognostic factor in gastric cancer.

Supporting Evidence

  • The 5-year survival rates were significantly different based on the metastatic lymph node ratio.
  • The metastatic lymph node ratio was found to be an independent prognostic factor.
  • Patients with a higher metastatic lymph node ratio had worse survival outcomes.

Takeaway

This study found that the ratio of metastatic lymph nodes to total lymph nodes removed can help predict how well patients with gastric cancer will do after treatment.

Methodology

Retrospective review of 224 gastric cancer cases with more than D1 dissection, assessing the relationship between metastatic lymph node ratio and prognosis.

Potential Biases

Potential selection bias due to exclusion criteria.

Limitations

The study is retrospective and may not account for all confounding factors.

Participant Demographics

{"sex":{"male":153,"female":71},"age":{"≤ 60":114,"> 60":110}}

Statistical Information

P-Value

p<0.001

Confidence Interval

95% confidence interval for hazard ratios varies by metastatic lymph node ratio category.

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-7-200

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication